What does the evidence say about Vitamin B1 Cognition Meta-Analysis?

Updated August 2026

Quick Answer

Vitamin B1 Cognition Meta-Analysis has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: In the United States, while mortality attributed to heart disease, stroke, and human immunodeficiency virus (HIV) declined between 2000 and 2021, deaths related to Alzheimer's disease increased by more than 140% [].

Key Takeaways

  • 01In the United States, while mortality attributed to heart disease, stroke, and human immunodeficiency virus (HIV) declined between 2000 and 2021, deaths related to Alzheimer's disease increased by more than 140% []. [Muacevic Alexander (2026)]
  • 025 8 Existing evidence from different studies has shown that these factors may exert their effect through different mechanisms, including neurobiological pathways, by activating sensorineural networks in the prefrontal and hippocampal areas of the brain, hippocampal atrophy, reduction in brain volume, and interaction with genetic risk factor components, such as APOEe4 [-]. [Muacevic Alexander (2026)]
  • 03With the burden of dementia increasing, and the potential for prevention through modifiable lifestyle factors, there is therefore a need for more research into specific predisposing and progression risk factors in order to develop a comprehensive and preventive strategy []. [Muacevic Alexander (2026)]
  • 041 Dementia is a major cause of individuals becoming dependent, especially among the elderly. [Muacevic Alexander (2026)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin B1 Cognition Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - In the United States, while mortality attributed to heart disease, stroke, and human immunodeficiency virus (HIV) declined between 2000 and 2021, deaths related to Alzheimer's disease increased by more than 140% []. [Muacevic Alexander (2026); evidence level 1] - 5 8 Existing evidence from different studies has shown that these factors may exert their effect through different mechanisms, including neurobiological pathways, by activating sensorineural networks in the prefrontal and hippocampal areas of the brain, hippocampal atrophy, reduction in brain volume, and interaction with genetic risk factor components, such as APOEe4 [-]. [Muacevic Alexander (2026); evidence level 1] - With the burden of dementia increasing, and the potential for prevention through modifiable lifestyle factors, there is therefore a need for more research into specific predisposing and progression risk factors in order to develop a comprehensive and preventive strategy []. [Muacevic Alexander (2026); evidence level 1] - 1 Dementia is a major cause of individuals becoming dependent, especially among the elderly. [Muacevic Alexander (2026); evidence level 1] - Concurrently, the number of individuals affected by dementia is anticipated to nearly triple by 2050, with associated treatment costs projected to reach US$2.8 trillion by 2030 []. [Liu Xing (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Determining the Effects of Lifestyle Factors Including Smoking, Alcohol Consumption, Physical Activity, and Diet on the Risk and Progression of Dementia: A Systematic Review
  2. Nutritional supplements and cognition in healthy aging and mild cognitive impairment patients: a systematic review and network meta-analysis